The kinase overexpression rates identified by OPPTI showed a high correlation between the two cohorts (Pearson correlation test, R = 0.44, p = 5e-10), where CDK6 and PDGFRB displayed the largest overexpression rates among the potential HCC drug targets (Figure S3). Here, CDK6 is linked to hepatocellular carcinoma.